Summary Comparison Table
Receptor GHRHR GHS-R1a Mechanism Gs/cAMP Gq/PKC/Ca²⁺ Half-life (rat) ~2 hours ~30-40 min GH Pattern Pulsatile Sustained Moderate DPP-IV Susceptible Resistant N/A FDA status Research Approved (specific indication) Table 3: Sermorelin vs. major GH secretagogue r
This comparison does not assign a generated winner or score.
- Receptor
- GHRHR
- GHS-R1a
- Mechanism
- Gs/cAMP
- Gq/PKC/Ca²⁺
- Half-life (rat)
- ~2 hours
- ~30-40 min
- GH Pattern
- Pulsatile
- Sustained
- Moderate
- DPP-IV
- Susceptible
- Resistant
- N/A
- FDA status
- Research
- Approved (specific indication)
- Table 3: Sermorelin vs. major GH secretagogue research analogs.